beta-Escin

Star0

DB15774InvestigationalSmall molecule

beta-Escin is an anti-inflammatory and vasoconstrictive agent indicated to treat minor muscle and joint trauma.

Formula / weight: C₅₅H₈₆O₂₄ · 1131.269 g/mol (avg)
Also known as: Aescin B · beta-Aescin
Code names: EINECS 247-619-4

Resolves to

Compound

UNIIQYK0D6H79OCAS26339-90-2ChEMBLCHEMBL505939ChEBI2500KEGGC08921

Clinical / RWD

RxNorm1476

Structure

InChIKeyAXNVHPCVMSNXNP-OXPBSUTMSA-NSMILES

[H][C@@]1(O[C@H]2[C@H](O)[C@@H](O[C@]3([H])O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@]([H])(O[C@H]3CC[C@@]4(C)[C@@]([H])(CC[C@]5(C)[C@]4([H])CC=C4[C@]6([H])CC(C)(C)[C@@H](OC(=O)C(\C)=C/C)[C@H](OC(C)=O)[C@]6(CO)[C@H](O)C[C@@]54C)[C@@]3(C)CO)O[C@@H]2C(O)=O)O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O

What you can answer from here — as of March 06, 2025

9Structured indicationsCondition, population, route and combination as fields, not prose

12ContraindicationsEach with its own population and attribute set

15Marketed productsAcross 3 countries and 6 labellers

1+ReferenceStructured and connected to the statements they support

Which other approved drugs treat the same conditions as beta-Escin, and which companies have late-stage candidates in those indications?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account